Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
Publication Type:
Journal Article
Authors:
J J Feld;
Kowdley, K.V.;
Coakley, E.;
Sigal, S.;
David R. Nelson;
Crawford, D.;
Weiland, O.;
Aguilar, H.;
Xiong, J.;
Pilot-Matias, T.;
DaSilva-Tillmann, B.;
Larsen, L.;
Podsadecki, T.;
Bernstein, B.Source:
N Engl J Med, Volume 370, Issue 17, p.1594-1603 (2014)
Keywords:
analysis,
Asthenia,
Australia,
Body Weight,
Chicago,
Diarrhea,
Disease,
Florida,
Genotype,
genotype 1,
HCV,
hepatitis,
Hepatitis C,
hepatitis C virus,
Infection,
Liver,
Louisiana,
Medicine,
methods,
Nausea,
New York,
NS5A inhibitor,
Patients,
peginterferon,
Placebos,
protease inhibitor,
Pruritus,
Research,
Research Support,
Ribavirin,
ritonavir,
sustained virologic response,
Telaprevir,
treatment
